We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+8.12%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.69B
AUM Growth
+$108M
Cap. Flow
-$1.54M
Cap. Flow %
-0.09%
Top 10 Hldgs %
32.32%
Holding
211
New
11
Increased
45
Reduced
84
Closed
4

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.77M
2
MTD icon
Mettler-Toledo International
MTD
+$2.46M
3
ALB icon
Albemarle
ALB
+$2.34M
4
NKE icon
Nike
NKE
+$1.67M
5
ROK icon
Rockwell Automation
ROK
+$1.67M

Top Sells

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$6.64M
2
GEV icon
GE Vernova
GEV
+$3.03M
3
MDT icon
Medtronic
MDT
+$1.91M
4
MSFT icon
Microsoft
MSFT
+$1.64M
5
ZBH icon
Zimmer Biomet
ZBH
+$1.44M

Sector Composition

Rank Sector Weight
1 Technology 28.35%
2 Healthcare 17.96%
3 Industrials 17.05%
4 Financials 9.04%
5 Materials 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRA
101
DELISTED
Coterra Energy
CTRA
$1.2M 0.07%
50,104
– –
BMRN icon
102
BioMarin Pharmaceuticals
BMRN
$12B
$1.17M 0.07%
16,661
+425
+3% +$35.5K
IWB icon
103
iShares Russell 1000 ETF
IWB
$47.9B
$1.17M 0.07%
3,723
– –
MCD icon
104
McDonald's
MCD
$194B
$1.16M 0.07%
3,802
– –
BC icon
105
Brunswick
BC
$5.33B
$1.12M 0.07%
13,405
-1,100
-8% -$85.4K
WLY icon
106
John Wiley & Sons Class A
WLY
$2.76B
$1.12M 0.07%
23,117
-7,143
-24% -$328K
ABBV icon
107
AbbVie
ABBV
$465B
$1.09M 0.06%
5,532
-300
-5% -$56K
UNP icon
108
Union Pacific
UNP
$175B
$1.08M 0.06%
4,398
– –
WAT icon
109
Waters Corp
WAT
$37.7B
$1.05M 0.06%
2,910
– –
NVO
110
Novo Nordisk
NVO
$225B
$1.02M 0.06%
8,534
-20
-0.2% -$2.67K
ETN icon
111
Eaton
ETN
$150B
$992K 0.06%
2,994
+140
+5% +$42.8K
KMB icon
112
Kimberly-Clark
KMB
$37.5B
$962K 0.06%
6,760
-33
-0.5% -$4.68K
V icon
113
Visa
V
$697B
$944K 0.06%
3,435
-50
-1% -$13.5K
FUL icon
114
H.B. Fuller
FUL
$3.07B
$939K 0.06%
11,824
– –
VHT icon
115
Vanguard Health Care ETF
VHT
$18.6B
$859K 0.05%
3,045
– –
J icon
116
Jacobs Solutions
J
$16.6B
$847K 0.05%
6,538
-1,288
-16% -$155K
NEE icon
117
NextEra Energy
NEE
$186B
$829K 0.05%
9,806
+510
+5% +$39.8K
GMAB icon
118
Genmab
GMAB
$17.8B
$789K 0.05%
32,363
+6,610
+26% +$177K
PM icon
119
Philip Morris
PM
$312B
$787K 0.05%
6,484
– –
TSLA icon
120
Tesla
TSLA
$1.21T
$753K 0.04%
2,877
– –
TGT icon
121
Target
TGT
$65.5B
$751K 0.04%
4,816
– –
BDX icon
122
Becton Dickinson
BDX
$45.8B
$707K 0.04%
2,934
-56
-2% -$13.1K
MUB icon
123
iShares National Muni Bond ETF
MUB
$45.3B
$686K 0.04%
6,312
– –
BMY icon
124
Bristol-Myers Squibb
BMY
$130B
$674K 0.04%
13,019
-65
-0.5% -$3.05K
FCX icon
125
Freeport-McMoran
FCX
$88.6B
$673K 0.04%
13,484
– –
3 4
5
6 7

Similar funds

HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
BCMIO
Beacon Capital Management Inc (Ohio) Dayton, Ohio $1.78B AUM 14.7% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $1.78B AUM 22.52% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return

Grandfield & Dodd's Q3 2024 Portfolio in Review

As of Q3 2024, Grandfield & Dodd held 211 positions worth $1.69B, up 6.8% from $1.58B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grandfield & Dodd's Q3 2024 filing shows 11 new, 45 increased, 84 reduced and 4 closed positions. Its largest new stake was Alnylam Pharmaceuticals: 1,224 shares worth $337K. The largest sale was Berkshire Hathaway Class A, an estimated $6.64M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q3 2024 buy was Alnylam Pharmaceuticals: 1,224 shares worth $337K.
  • Grandfield & Dodd added most to Alphabet (Google) Class A in Q3 2024, an estimated $3.77M increase.
  • Grandfield & Dodd's biggest Q3 2024 reduction was Berkshire Hathaway Class A, cutting an estimated $6.64M.
  • Grandfield & Dodd fully exited Charles Schwab in Q3 2024, selling an estimated $265K.
  • Grandfield & Dodd's ten largest holdings make up 32% of its $1.69B portfolio in Q3 2024.
  • Grandfield & Dodd opened 11 new positions and closed 4 in Q3 2024.
  • Grandfield & Dodd's portfolio value rose 6.8% quarter-over-quarter to $1.69B.

Based on Grandfield & Dodd's 13F filing for Q3 2024, filed 8 Nov 2024.